F. Peyvandi Et Al. , "Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis," JOURNAL OF THROMBOSIS AND HAEMOSTASIS , vol.16, no.1, pp.39-43, 2018
Peyvandi, F. Et Al. 2018. Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , vol.16, no.1 , 39-43.
Peyvandi, F., Cannavo, A., Garagiola, I., Palla, R., Mannucci, P. M., & Rosendaal, F. R., (2018). Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , vol.16, no.1, 39-43.
Peyvandi, Osman Et Al. "Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis," JOURNAL OF THROMBOSIS AND HAEMOSTASIS , vol.16, no.1, 39-43, 2018
Peyvandi, Osman B. Et Al. "Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis." JOURNAL OF THROMBOSIS AND HAEMOSTASIS , vol.16, no.1, pp.39-43, 2018
Peyvandi, F. Et Al. (2018) . "Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis." JOURNAL OF THROMBOSIS AND HAEMOSTASIS , vol.16, no.1, pp.39-43.
@article{article, author={Osman Bülent ZÜLFİKAR Et Al. }, title={Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis}, journal={JOURNAL OF THROMBOSIS AND HAEMOSTASIS}, year=2018, pages={39-43} }